25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome

References

• Aprinodze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;90:1929–35
   PubMedGoogle Scholar
• Ehrmann DA. Insulin resistance and polycystic ovary syndrome. Curr Diab Rep 2002;2:71–6
   PubMedGoogle Scholar
• Kandarakis ED, Papavassilou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome Trends Mol Med 2006;12:352–62
   Google Scholar
• Scragg R, Jackson R, Holdaway IM, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990;19:559–63
   PubMed Web of Science ®Google Scholar
• Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820–5
   PubMed Web of Science ®Google Scholar
• Homburg R, Amsterdam A. Polycystic ovary syndrome – loss of the apoptotic mechanism in the ovarian follicles? J Endocrinol Invest 1998;21:552–7
   PubMed Web of Science ®Google Scholar
• Tilly JL. Apoptosis and ovarian function. Rev Reprod 1996;1:162–72
   PubMedGoogle Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Metab Endocrinol 1999;84:3666–72
   PubMed Web of Science ®Google Scholar
• Nestler JE, Reilly ER, Cheang KI, et al. A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. Trans Am Clin Climatol Assoc. 2012;123:209–19
   Google Scholar
• Wehr E, Trummer O, Giuliani A, et al.Vitamin D associated polymorphisms are related to insulin resistance and vitamin D deficiency in PCOS. Eur J Endocrinol 2011;164:741–9
   PubMed Web of Science ®Google Scholar
• Mahmoudi T, Gourabi H, Ashrafi M, et al. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010;93:1208–14
   PubMed Web of Science ®Google Scholar
• Li HW, Brereton RE, Anderson RA, et al. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metab Clin Exp 2011;60:1475–81
   PubMed Web of Science ®Google Scholar
• Wehr E, Pilz S, Schweighofer N, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009;161:575–82
   PubMed Web of Science ®Google Scholar
• Maestro B, Molero S, Bajo S, et al. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D[3]. Cell Biochem Funct 2002;20:227–32
   PubMed Web of Science ®Google Scholar
• Maestro B, Davila N, Carranza MC, Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003;84:223–30
   PubMed Web of Science ®Google Scholar
• Milner RD, Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 1967;3:47–9
   PubMedGoogle Scholar
• Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169–80
   PubMed Web of Science ®Google Scholar
• Hahn S, Haselhorst U, Tan S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006;114:577–83
   PubMed Web of Science ®Google Scholar
• Patra SK, Nasrat H, Goswami B, et al. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr 2012;6:146–9
   PubMedGoogle Scholar
• Selimoglu H, Duran C, Kiyici S, et al. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 2010;33:234–8
   PubMed Web of Science ®Google Scholar
• Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 2009;92:1053–8
   PubMed Web of Science ®Google Scholar
• Ardabili HR, Gargari BP, Farzadi L, et al. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 2012;32:195–201
   PubMed Web of Science ®Google Scholar
• Pal L, Berry A, Coraluzzi L, et al. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 2012;28:965–8
   Web of Science ®Google Scholar
• Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 2013;28:777–84
   PubMed Web of Science ®Google Scholar
• Panidis D, Balaris C, Farmakiotis D, et al. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 2005;51:1691–7
   PubMed Web of Science ®Google Scholar
• Yildizhan R, Kurdoglu M, Adali E, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2008;280:559–63
   Google Scholar
• Muscogiuri G, Policola C, Prioletta A, et al. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin Nutr. 2012;31:476–80
   PubMed Web of Science ®Google Scholar
• Lagunova Z, Porojnicu AC, Lindberg F, et al. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009;29:3713–20
   PubMed Web of Science ®Google Scholar
• Parikh G, Varadinova M, Suwandhi P, et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res 2010;42:754–7
   PubMed Web of Science ®Google Scholar
• Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157–61
   PubMed Web of Science ®Google Scholar